OS Therapies Announces Successful Type C Meeting with US FDA Regarding Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected…

FDA confirmed that data from single-arm studies in rare diseases, such as in ultra-rare deadly pediatric cancer osteosarcoma, ...
Simcoe.com

Canada hit a major EV milestone in 2025 — but sales are crashing. Here’s why and what needs to be done

Electric Mobility Canada said electric and plug-in hybrid vehicles make up four to five per cent of all light-duty vehicles ...

Fortescue to Acquire Alta Copper for C$1.40 per Share

VANCOUVER, BC / ACCESS Newswire / December 14, 2025 / Alta Copper Corp. (TSX:ATCU)(OTCQX:ATCUF)(BVL:ATCU) ("Alta Copper" or ...